Hosted on MSN8mon
GSK’s Blenrep combo therapy meets key goal in multiple myeloma trial
The trial evaluated Blenrep (belantamab mafodotin), in combination ... a combination therapy for the relapsed or refractory multiple myeloma. DREAMM-8 is the second phase III head-to-head ...
pharmaphorum4y
FDA approves GSK's Blenrep for advanced multiple myeloma
The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease. Blenrep (belantamab mafodotin) has been ...
pharmaphorum6d
GSK scores again with Blenrep in multiple myeloma
GSK continues to build the case for its multiple myeloma therapy Blenrep, which was pulled from the US market last year, with another positive phase 3 trial. The BCMA-targeted antibody-drug ...
Hosted on MSN3mon
GSK Blenrep Combos for Multiple Myeloma Accepted for EU Review
seeking approval for the Blenrep (belantamab mafodotin) combination therapy to treat relapsed or refractory multiple myeloma (RRMM) for review. The MAA seeks the approval of Blenrep in combination ...
FiercePharma3d
J&J angles Darzalex for first move into early-stage myeloma with trial win, FDA filing
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
The American Journal of Managed Care4d
Eque-Cel CAR T Shows Strong Results for Multiple Myeloma
Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...
Science Daily7mon
Multiple Myeloma News
4, 2024 — A new study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma.
Targeted Oncology4d
FDA Grants Orphan Drug Designation to LBL-034 in Multiple Myeloma
The FDA has granted LBL-034 orphan drug designation for relapsed/refractory multiple myeloma treatment. LBL-034 has received ...
BioSpace5d
Gilead, Arcellx Tout Best-in-Class Potential for CAR T Therapy in Multiple Myeloma
Truist Securities analyst Asthika Goonewardene in an investor note said data for anito-cel—particularly its safety ...
Healthline10d
What Are the CRAB Symptoms of Multiple Myeloma?
Multiple myeloma is a type of cancer where plasma cells in bone marrow replicate out of control. Doctors use the acronym CRAB to diagnose myeloma by identifying four symptoms. The National Cancer ...
WebMD1y
Multiple Myeloma Resource Center
A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...
Medscape6mon
Multiple Myeloma News
MDedge News, May 08, 2024 Do No Harm: What Smoldering Myeloma Teaches Us Manni Mohyuddin, MD, highlights how he treats smoldering multiple myeloma ... experimental drug Blenrep helped extend ...